CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: trandolaprilat
Accession: CHEBI:141521
browse the term
Definition: A heterobicyclic compound that is trandolapril in which the ethyl ester group has been hydrolysed to the corresponding acid group. It is the active metabolite of the prodrug trandolapril.
Synonyms: exact_synonym: (2S,3aR,7aS)-1-[(2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid
related_synonym: (2S,3aR,7aS)-1-((S)-N-((S)-1-carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid; 1-(2-((1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)octahydro-1H-indole-2-carboxylic acid; Formula=C22H30N2O5; InChI=1S/C22H30N2O5/c1-14(23-17(21(26)27)12-11-15-7-3-2-4-8-15)20(25)24-18-10-6-5-9-16(18)13-19(24)22(28)29/h2-4,7-8,14,16-19,23H,5-6,9-13H2,1H3,(H,26,27)(H,28,29)/t14-,16+,17-,18-,19-/m0/s1; InChIKey=AHYHTSYNOHNUSH-HXFGRODQSA-N; RU 44403; RU44403; SMILES=[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC3=CC=CC=C3)C(O)=O)[C@@]1([H])CCCC2)C(O)=O; trandolapril diacid; trandolaprilate; trandolaprilatum
xref: CAS:87679-71-8; Chemspider:4576532; DrugBank:DB14209; HMDB:HMDB0060583; KEGG:C21515; PDBeChem:X93; PMID:11409646; PMID:12736518; PMID:17117442; PMID:20488190; PMID:2478763; PMID:2551273; PMID:25864194; PMID:2847673; PMID:3383998; PMID:7527094; PMID:7527103; PMID:7531766; PMID:8258671; PMID:8396059; Patent:CN101302185; Patent:CN101460459; Reaxys:8875886
G
Ace
angiotensin I converting enzyme
decreases activity
EXP
trandolapril results in decreased activity of ACE protein
CTD
PMID:27428043
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
multiple interactions
ISO
trandolapril promotes the reaction [REN2 protein results in increased expression of ACE2 protein]
CTD
PMID:27428043
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Ache
acetylcholinesterase
multiple interactions
EXP
trandolapril inhibits the reaction [3-nitropropionic acid results in increased activity of ACHE protein]
CTD
PMID:25445565
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Adrb1
adrenoceptor beta 1
increases expression
EXP
trandolapril results in increased expression of ADRB1 protein
CTD
PMID:7586371
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
G
Agt
angiotensinogen
multiple interactions decreases expression
EXP ISO
trandolapril inhibits the reaction [Isoproterenol results in increased expression of AGT protein] trandolapril inhibits the reaction [REN2 protein results in increased expression of AGT protein modified form] trandolapril results in decreased expression of AGT protein modified form
CTD
PMID:1534315 PMID:27428043
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Cat
catalase
multiple interactions
EXP
trandolapril inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]
CTD
PMID:25445565
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cyba
cytochrome b-245 alpha chain
multiple interactions decreases expression
EXP
[trandolapril co-treated with eplerenone] results in decreased expression of CYBA mRNA trandolapril results in decreased expression of CYBA mRNA
CTD
PMID:17324946
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
G
Fn1
fibronectin 1
multiple interactions
EXP
[trandolapril co-treated with eplerenone] results in decreased expression of FN1 protein
CTD
PMID:17324946
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Ncf1
neutrophil cytosolic factor 1
multiple interactions decreases expression
EXP
[trandolapril co-treated with eplerenone] results in decreased expression of NCF1 mRNA; [trandolapril co-treated with eplerenone] results in decreased expression of NCF1 protein trandolapril results in decreased expression of NCF1 mRNA; trandolapril results in decreased expression of NCF1 protein
CTD
PMID:17324946
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Ren
renin
multiple interactions increases expression
ISO EXP
[Bumetanide co-treated with trandolapril] results in increased expression of REN protein trandolapril results in increased expression of REN protein
CTD
PMID:16635047 PMID:27428043
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
G
Slc15a1
solute carrier family 15 member 1
multiple interactions
ISO
trandolapril inhibits the reaction [SLC15A1 protein results in increased uptake of glycylsarcosine]
CTD
PMID:18713951
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
G
Slc15a2
solute carrier family 15 member 2
multiple interactions
EXP
trandolapril inhibits the reaction [SLC15A2 protein results in increased uptake of glycylsarcosine]
CTD
PMID:18713951
NCBI chr11:64,014,182...64,043,228
Ensembl chr11:64,014,182...64,043,225
G
Sod2
superoxide dismutase 2
increases expression
EXP
trandolapril results in increased expression of SOD2 protein
CTD
PMID:17324946
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all